Skip to main content
Home

Accessibility Statement

Accessibility Statement for Boehringer Ingelheim websites

Boehringer Ingelheim is committed to providing a website that is accessible to the widest possible audience, regardless of technology or ability. We are actively working to increase the accessibility and usability of our website and in doing so adhere to many of the available standards and guidelines. These guidelines explain how to make web content more accessible for people with disabilities. Conformance with these guidelines will help make the internet more user friendly for all people. We are continually seeking out solutions that will bring all areas of the Site up to the same level of overall web accessibility.

Access Keys

Hot keys provide short cuts to certain pages within the web site. The hot keys may vary dependant on the internet browser you are using and the device, please see below for the details on how to access the hot key function for;

Chrome: ALT + hot key number
Internet Explorer: ALT + hot key number + Enter
Firefox: Alt + Shift + hot key number

The following shortcut hot keys are active on the Boehringer Ingelheim website:

0 Accessibility page

1 Homepage

2 Site Map

3 Search

4 Contact

5 Print

We try to offer a clear navigation structure that helps you to find the content you are looking for in an easy and quick way.

Links contain title attributes which describe content and make sense out of context.

The use of short sentences and paragraphs and multiple entry points to additional information sources e.g. via teaser elements and related content areas will make it easier to comprehend the content.

In the meantime, should you experience any difficulty in accessing the Boehringer Ingelheim website, please do not hesitate to contact us.

Please be aware that this website contains promotional information about Boehringer Ingelheim medicines and services. Some of this may not be directly relevant to your scope of practice and it is your own decision whether you choose to view this information.

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard.
Adverse events should also be reported to Boehringer Ingelheim Drug Safety on 0800 328 1627 (freephone).

  • Accessibility Statement
  • Privacy and Cookie Policy
  • Terms of Use
  • Product Information
© 1999-2018 Boehringer Ingelheim GmbH All rights reserved.